Simson et al. (1) claim to have developed a technique for inflicting brain lesions that spares nerve fibers. In view of the importance of a solution to the "fiber of passage problem," certain features of this report require comment. First, Simson et al. neglected to cite a number of studies on the central excitatory and neurotoxic effects of glutamate and its analogs that followed Olney's early studies of monosodium glutamate in the hypothalamus (2-4). In three of these studies the compound was injected intracerebrally outside the hypothalamus, and all the studies contained evidence directly relevant to the fiber of passage problem. In the context of these studies, We agree with Merker that more data are needed to confirm our monosodium-L-glutamate (MSG) axon-of-passage sparing lesioning technique. Since our report (1) was published, we have infused MSG into other brain regions, and in each case found evidence of fiber sparing. These regions include medulla (Weigert-Weil myelin stain) (2), caudate nucleus (Weigert-Weil stain and histofluorescence) (3), and optic tract (electrophysiology) (4). Electrophysiological recordings from the heavily myelinated optic tract show that persistent evoked potentials can be induced by light flashes after the infusion of MSG into the optic tract (4). Multiple-unit electrophysiological recordings from a cellular area (paraventricular nucleus) showed a gradual decline in activity starting 11/2 hours after the infusion of MSG into the paraventricular nucleus (4). By 3 hours after infusion there was virtually no activity in the infused area. These findings support our suggestion that MSG spares fibers of passage, while indicating that it does affect cell bodies.
Simson et al. (1) claim to have developed a technique for inflicting brain lesions that spares nerve fibers. In view of the importance of a solution to the "fiber of passage problem," certain features of this report require comment. First, Simson et al. neglected to cite a number of studies on the central excitatory and neurotoxic effects of glutamate and its analogs that followed Olney's early studies of monosodium glutamate in the hypothalamus (2) (3) (4) . In three of these studies the compound was injected intracerebrally outside the hypothalamus, and all the studies contained evidence directly relevant to the fiber of passage problem. In the context of these studies, the report of Simson et al. adds strength to the case for glutamate analogs as fibersparing lesion agents [see (3) , and discussion in (5) (4) . Multiple-unit electrophysiological recordings from a cellular area (paraventricular nucleus) showed a gradual decline in activity starting 11/2 hours after the infusion of MSG into the paraventricular nucleus (4) . By 3 hours after infusion there was virtually no activity in the infused area. These findings support our suggestion that MSG spares fibers of passage, while indicating that it does affect cell bodies.
With regard to the proposal that kainic acid is a selective lesioning agent (5), although we have no evidence of our own, others (6) have recently questioned the selectivity of kainic acid lesions. The nigrostriatal dopamine system, commonly used to test this selectivity, has cell bodies located in the substantia nigra and terminals that synapse in the striatum. 
